ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag cell molecular biology science policy funding cancer

DNA molecule.
Finding DNA Tags in AAV Stacks
Mariella Bodemeier Loayza Careaga, PhD | Mar 7, 2024 | 8 min read
Ten years ago, scientists put DNA barcodes in AAV vectors, creating an approach that simplified, expedited, and streamlined AAV screening. 
Microfluidics: Biology’s Liquid Revolution
Laura Tran, PhD | Feb 26, 2024 | 8 min read
Microfluidic systems redefined biology by providing platforms that handle small fluid volumes, catalyzing advancements in cellular and molecular studies.
Lasker Award winner Piet Borst sits at his desk.
A Journey With Metabolism, Parasites, and Cancer
Laura Tran, PhD | Sep 21, 2023 | 7 min read
Piet Borst led stellar work on cell organelles, trypanosomes, and cancer drug resistance during the golden age of biology.
Image showing monoclonal antibody treatment
The Resilience of Monoclonal Antibodies and their Makers
Laura Tran, PhD | Mar 15, 2024 | 10+ min read
The road to developing monoclonal antibodies for effectively targeting cancer was paved with tenacity, passion, and strokes of luck.
A close up of several modular puzzle pieces.
Making Connections: Click Chemistry and Bioorthogonal Chemistry
Deanna MacNeil, PhD | Feb 13, 2024 | 5 min read
Simple, quick, and modular reactions allow researchers to create useful molecular structures from a wide range of substrates.
One Protein to Rule Them All
Shelby Bradford, PhD | Feb 28, 2024 | 10+ min read
p53 is possibly the most important protein for maintaining cellular function. Losing it is synonymous with cancer.
Speaking of Science
The Scientist | Jan 1, 2012 | 2 min read
January 2012's selection of notable quotes
Speaking of Science Policy
Tracy Vence | Feb 20, 2017 | 2 min read
Notable quotes from the American Association for the Advancement of Science annual meeting
Cultivating Policy from Cell Types
Eugene Russo | May 27, 2001 | 7 min read
For better or worse, stem cell science has become inextricably married to stem cell politics. Policymakers who oppose public financing of embryonic stem cells have used recent adult stem cell findings to argue for a dismissal of the NIH stem cell guidelines (see "On the Brink," page 1). The guidelines, finalized last summer during the Clinton administration, call for funding the use, but not derivation, of human embryonic stem cells (ESCs); the pro-life Bush administration appears ready to ban t

Run a Search

ADVERTISEMENT